Phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma | Dr Sumanta Pal at Annual Meeting 2015

Phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma | Dr Sumanta Pal at Annual Meeting 2015

User Photo
EMJ

5 years
546 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sumanta K. Pal, MD, of City of Hope Comprehensive Cancer Center, Duarte, CA, discusses the results of a randomised, phase 2, three-arm trial of lenvatinib, everolimus, and lenvatinib combined with everolimus in patients with metastatic renal cell carcinoma.
Up Next Autoplay